China-based MGI Tech has announced a milestone collaboration with Eurofins Genomics Europe Genotyping A/S, which has placed a corporate order of the revolutionary DNBSEQ-T20×2 (T20), ultra-high throughput sequencer, along with the genomics data center ZTRON Appliance and a range of MGI's state-of-the-art laboratory automation products and systems. This marks the first corporate order of the T20 in the Europe region, signaling a significant advancement in precision health initiatives across the continent.

Powered by MGI's proprietary DNBSEQ^T technology, T20 represents a breakthrough in genetic sequencing by significantly reducing sequencing costs to below $100 per genome when running 50,000 WGS per year, garnering global attention. Specifically designed to address the most challenging sequencing scenarios, T20 caters to a wide array of high-throughput sequencing needs in scientific and clinical research, including WGS, WGBS, stLFR, single-cell sequencing, Stereo-seq, and more.

Following its launch in February 2023, T20 has gained widespread adoption among globally leading research institutions and healthcare providers.

The collaboration between MGI and Eurofins Genomics signifies a synergy of expertise and resources that promises to drive advancement in genomics research and clinical applications.